Oculam, Adelaida .

HRN: 10-74-94  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/07/2025
CEFTRIAXONE 1G (VIAL)
06/07/2025
06/14/2025
IV
2 Grams
Q24
T/C Thyroid CA
Checking Initial Appropriateness 
07/29/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
07/29/2025
08/05/2025
IV
1.5g
Q6
Bleeding Thyroid Carcinoma
Checking Initial Appropriateness 
08/04/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
08/04/2025
08/11/2025
IV
1.5g
Q6hrs
Bleeding Thyroid CA
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: